Lenvatinib 4 mg

Lenvatinib 4 mg is a targeted cancer therapy used to treat various types of thyroid cancer, including advanced or metastatic thyroid cancer. It works by blocking the growth and spread of cancer cells.

Uses: Lenvatinib 4 mg is primarily used to treat:

• Advanced or metastatic thyroid cancer
• Other types of cancer as determined by a healthcare professional

Important Considerations (Prescription Required):

1. Severe Side Effects: Lenvatinib can cause severe side effects, including high blood pressure, bleeding, and protein in the urine. It is essential to consult with a healthcare professional before starting treatment.
2. Prescription Only: Lenvatinib is a prescription medication and should only be used under the guidance of a qualified medical professional.
3. Regular Monitoring: During treatment, regular monitoring is necessary to assess for side effects and adjust the dosage as needed.